Physician profile
Scott R Matson
NPI 1306896162
$1,324.09
in general payments reported to CMS, 2019-2025
8 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.01 · 2020: $25.42 · 2021: $136 · 2022: $239 · 2023: $371 · 2024: $334 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $897.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $676.91 | 2019-2025 | Arexvy, Nucala, Trelegy Ellipta |
| Pfizer INC. | $491.24 | 2021-2024 | |
| Abbvie INC. | $54.74 | 2019-2022 | |
| Merz North America, INC. | $46.01 | 2021-2022 | |
| Myovant Sciences INC. | $15.80 | 2021 | |
| Novo Nordisk INC | $14.05 | 2021 | |
| Dysis Medical, INC. | $13.18 | 2021 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Matson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.